SEC registrant · CIK 0001521420

PROTO SCRIPT PHARMACEUTICAL CORP

PROTO SCRIPT PHARMACEUTICAL CORP (CIK 0001521420, EIN 99-0363803) reported revenue of $788,960 for FY2016 (2016-01-01 to 2016-12-31) and net income of -$7.18 million (-$7,182,722) for FY2016 (2016-01-01 to 2016-12-31), as filed in its 10-K/A filed 2017-10-19 (accession 0001640334-17-002207).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001521420
EIN99-0363803
SIC industry code7330 Services-Mailing, Reproduction, Commercial Art & Photography
State or country of incorporationNV
Fiscal year endDecember 31
Filer categorySmaller reporting company
Entity typeoperating
Olympus entity IDorg_30824r772ts9345jzkbj0drqap
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$788,960FY20162016-01-01 to 2016-12-3110-K/A2017-10-190001640334-17-002207SalesRevenueNet
Net income-$7,182,722FY20162016-01-01 to 2016-12-3110-K/A2017-10-190001640334-17-002207NetIncomeLoss
Total assets$170,191FY2016as of 2016-12-3110-K/A2017-10-190001640334-17-002207Assets
Total liabilities$88,812FY2016as of 2016-05-3110-K2016-08-190001078782-16-003303Liabilities
Stockholders' equity-$319,736FY2016as of 2016-12-3110-K/A2017-10-190001640334-17-002207StockholdersEquity
Operating cash flow$44,105FY20162016-01-01 to 2016-12-3110-K/A2017-10-190001640334-17-002207NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Diluted earnings per share-$0.02 per shareFY20162016-01-01 to 2016-12-3110-K/A2017-10-190001640334-17-002207EarningsPerShareBasicAndDiluted
Shares outstanding49,139,998 sharesFY2016as of 2017-09-1410-K/A2017-10-190001640334-17-002207EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2007-2016, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20162016-01-01 to 2016-12-31$788,96010-K/A2017-10-190001640334-17-002207
RevenueFY20132012-06-01 to 2013-05-31$010-K2013-09-160001517126-13-000261
RevenueFY20122011-06-01 to 2012-05-31$010-K2013-09-160001517126-13-000261
Net incomeFY20162016-01-01 to 2016-12-31-$7,182,72210-K/A2017-10-190001640334-17-002207
Net incomeFY20162015-06-01 to 2016-05-31-$33,14310-K2016-08-190001078782-16-003303
Net incomeFY20152014-06-01 to 2015-05-31-$45,18010-K2016-08-190001078782-16-003303
Net incomeFY20142013-06-01 to 2014-05-31-$38,25910-K2016-05-240001562884-16-000025
Net incomeFY20132012-06-01 to 2013-05-31-$32,42310-K2014-10-090001517126-14-000315
Net incomeFY20122011-06-01 to 2012-05-31-$32,84710-K2013-09-160001517126-13-000261

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2018-03-082017-09-300001640334-18-000434pscr_10q.htm
10-Q2018-01-172017-06-300001640334-18-000110pscr_10q.htm
10-Q2017-11-222017-03-310001640334-17-002503pscr_10q.htm
10-K/A2017-10-192016-12-310001640334-17-002207pscr_10ka.htm
10-K2017-09-202016-12-310001640334-17-001999pscr_10k.htm
10-Q2017-01-062016-09-300001078782-17-000022f10q093016_10q.htm
10-Q/A2016-12-072016-06-300001078782-16-003925f10qa063016_10qz.htm
10-Q2016-11-182016-06-300001078782-16-003830f10q063016_10q.htm
10-K/A2016-11-072016-05-310001078782-16-003720f10ka053116_10kz.htm
10-K2016-08-192016-05-310001078782-16-003303f10k053116_10k.htm
10-Q2016-06-132016-02-290001562884-16-000037ynxg-20160229_10q.htm
10-Q2016-06-132015-11-300001562884-16-000035ynxg-20151130_10q.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001521420published by the sourcedata.sec.gov/submissions/CIK0001521420.json2026-10-21
Employer Identification Number (EIN) · US-EIN99-0363803published by the sourcedata.sec.gov/submissions/CIK0001521420.json2026-10-21

Former names

NameFromTo
YANEX GROUP, INC.2011-06-272016-10-06

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001521420.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001521420.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001521420" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001521420/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001521420/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1521420"}

On SEC EDGAR

About this data